Medical Properties Trust (MPT): A customer-map for investors
Medical Properties Trust (MPT) acquires, finances and owns healthcare real estate and monetizes primarily through long-term net leases and mortgage loans to healthcare operators; rent and interest income drive roughly 95% of revenue, while asset sales and joint-venture activity provide portfolio management optionality. For investors evaluating tenant risk and re‑tenanting progress, the critical questions are lease concentration, operator quality, and the pace at which re‑tenanted assets ramp to contractual rent.
If you want a concise, investor‑grade view of MPT’s customer relationships and the operational constraints that drive cash flow risk, read on — or visit Null Exposure for continuous monitoring and alerts: https://nullexposure.com/
The operating model in plain English: what drives upside and downside
MPT runs like an infrastructure REIT for healthcare real estate: it underwrites large, multi‑decade lease terms (typically 15+ years) with inflation escalators, centralizes management of a global portfolio and relies on a relatively small set of large operators for material cash flows. That model produces stable contractual cashflows in good operator scenarios but concentrated counterparty risk when operators face liquidity problems; tenant performance is explicitly material to MPT’s ability to service debt and pay distributions (FY2024 10‑K).
- Long-term landlord posture: MPT targets long fixed lease terms and mortgage financing; leases and loans are structured to transfer operating costs to tenants (FY2024 10‑K).
- Global footprint, centralized management: investments span the U.S., Europe and South America, supporting geographic diversification but also jurisdictional tax and operational complexity (FY2024 10‑K).
- Materiality of tenant health: tenant cash flow is a company‑level risk that can force impairments and re‑tenating work, as MPT disclosed in FY2024 (FY2024 10‑K).
- Ramping re‑tenanting: management communicated scheduled rent ramp milestones during re‑tenanting, with staged recovery to 100% contractual rent by year‑end 2026 (earnings commentary Jan 2025).
For more coverage on MPT’s tenant evolution and re‑tenanting progress, visit https://nullexposure.com/ — you’ll find curated signals and primary‑source tracking.
How to read the relationship summaries below
I list each named operator or counterparty that appears in the public record we reviewed, with a short, investor‑oriented summary and the natural source note that supports the claim. Where MPT cited the same tenant across multiple documents, the most representative source is used.
Relationship-by-relationship breakdown (investor summaries)
UCHealth
MPT sold 11 freestanding emergency departments to UCHealth for approximately $86 million in August 2024, realizing a gain on sale of ~$40 million. According to MPT’s FY2024 10‑K, the transaction closed on August 14, 2024 (FY2024 10‑K).
Swiss Medical
MPT holds an equity investment in Swiss Medical and marked it to fair value in Q3 2023 based on a new investor price, recording a CHF 20 million favorable adjustment; Swiss Medical is also listed among MPT’s largest tenants. (FY2024 10‑K).
Prime Healthcare Services, Inc.
MPT sold five properties to Prime in April 2024 for total proceeds of approximately $350 million, which included a $100 million mortgage loan that was repaid in August 2024; the sale generated a gain on sale of about $53 million. (FY2024 10‑K).
Dignity Health
MPT completed the sale of eight properties to Dignity Health in July 2024 for roughly $160 million and recognized a gain on sale of ~$85 million. (FY2024 10‑K).
CommonSpirit
MPT’s FY2024 disclosures note lease intangible amortization acceleration tied to operations acquired by CommonSpirit in 2023, reflecting prior contractual relationships and accounting recognition related to the May 1, 2023 acquisition. (FY2024 10‑K).
Orlando Health
MPT consented to the sale of three Florida facilities ("Space Coast" properties) to Orlando Health, with the transaction closing on October 23, 2024 per MPT filings. (FY2024 10‑K).
Pajaro Valley Healthcare District Corporation
Pajaro Valley exercised a purchase option on the Watsonville facility in Q3 2024, reflecting a tenant buyout of that asset under contractual purchase rights. (FY2024 10‑K).
LifePoint Behavioral / Lifepoint Behavioral Health
LifePoint Behavioral is a material tenant; MPT disclosed dependence on large tenants including Lifepoint Behavioral and noted that new leadership at LifePoint Behavioral is implementing programs to control costs and support revenue mix heading into 2026. (FY2024 10‑K; 2025 Q4 earnings call).
Circle Health / Circle Health Ltd.
Affiliates of Circle Health lease 36 U.K. facilities to MPT under separate lease agreements; Circle is named among MPT’s largest tenants. (FY2024 10‑K; earnings commentary 2025/2026).
Healthscope Ltd.
MPT sold 11 general acute care facilities in Australia operated by Healthscope in a transaction announced March 30, 2023 for approximately A$1.2 billion. (FY2024 10‑K).
Pipeline Health System, LLC
MPT referenced Pipeline as an example where, if a tenant assumes a lease in bankruptcy, pre‑bankruptcy balances would be collected in full; Pipeline was involved in earlier tenant bankruptcy matters. (FY2024 10‑K).
Priory / Priory Group
Affiliates of Priory Group lease 37 U.K. facilities to MPT; MPT highlighted Priory as a large tenant and discussed sectoral impacts from NHS budget constraints in 2026 commentary. (FY2024 10‑K; 2026 news commentary).
Prospect Medical Holdings / Prospect
MPT disclosed bankruptcy exposure to Prospect and has negotiated resolutions including sale agreements and replacement leases; Prospect historically leased multiple facilities and MPT has restructured exposure through new leases. (FY2024 10‑K; 2025‑2026 news and earnings commentary).
Swiss Medical Network
Affiliates of Swiss Medical Network lease 17 Swiss facilities via MPT’s Infracore SA joint venture; Swiss Medical Network reported solid growth in Europe in 2026. (FY2024 10‑K; 2026 earnings commentary).
GenesisCare
Three acute care facilities in Spain were acquired in 2022 and are leased to GenesisCare on long‑term leases with inflation escalators. (FY2024 10‑K).
Fundación Cardiovascular de Colombia
A general acute care facility in Colombia acquired in July 2022 was leased to Fundación Cardiovascular de Colombia under a long‑term lease with inflation escalators. (FY2024 10‑K).
Ernest Health
Ernest Health is a post‑acute operator in MPT’s portfolio that delivered double‑digit EBITDARM growth and plans operational conversions of LTAC facilities to IRFs by end of 2026, supporting rent coverage. (2025 Q4 earnings call; 2026 earnings transcript).
NOR Health Systems / NOR Healthcare Systems Corp.
MPT entered a new 15‑year lease with NOR in California expected to reach stabilized annual cash rent of $45 million by December; NOR is contractually ramping to full contractual rent through 2026. (2025 Q4 earnings call; 2026 news).
ATOS / Atos
Atos is referenced in MPT commentary as one of several international operators (e.g., HM Hospitales, eMDs, Atos) producing steady performance trends in 2026 earnings coverage. (2026 news/earnings transcript).
Steward Health Care / Steward Health Care System
MPT acquired Steward properties as part of earlier transactions and has since re‑tenanted many Steward hospitals after Steward’s financial collapse; MPT collected rent and negotiated operator transitions in 2024–2026. (News reporting 2021–2026; FY2024 disclosures).
Healthcare Systems of America (HSA / HSAI / HAS)
HSA is MPT’s third‑largest tenant by revenue share in late 2025 and became subject to legal notices and default declarations on several properties in early 2026, prompting investor and law‑firm scrutiny. (FY2024 10‑K; 2026 news coverage).
HonorHealth / Quorum
MPT noted Quorum and HonorHealth reached fully stabilized rents in late 2025; HSA was reported to be ramping payments and management projected full monthly payments beginning October (2026 earnings transcript).
Pihlajalinna / PIHLF
MPT leases hospitals to Pihlajalinna on long‑term agreements with annual inflation escalators as disclosed in the FY2024 filing. (FY2024 10‑K).
ChristianaCare / Crozer Health
MPT disclosed large impairment and sale discussions related to Crozer and Prospect properties, and ChristianaCare featured in preliminary sale agreements as part of mitigation of Prospect exposure. (FY2024 10‑K; 2023 news).
CRCE / Circle (ticker references)
CRCE is cited in FY2024 disclosures as part of the group of large tenants (Circle/CRCE). (FY2024 10‑K).
MEDIAN / Median / CHMD
MEDIAN operates German rehabilitation hospitals in an MPT joint venture that secured a €702.5m refinancing; MEDIAN reported strong operating periods in 2026 commentary. (2025 financing press; 2026 earnings).
PSEC
PSEC appears in coverage tied to Prospect re‑tenanting and to the broader leverage discussion; media commentary links PSEC to re‑leases and re‑tenanting progress in 2025–2026. (2025–2026 news).
Vibra / Vibra Healthcare / PETRY
MPT executed a new 20‑year master lease with Vibra and received a one‑time rent payment as part of restructuring; Vibra’s rehab division delivered substantial EBITDARM improvement in 2025. (2025 Q4 earnings call; 2026 news).
Select Medical / SEM
MPT noted a small number of properties are leased to Select Medical following re‑allocations from other operators, per earnings commentary. (2025 Q4 earnings call).
Surgery Partners / SGRY
Surgery Partners is referenced as a long‑standing tenant reporting healthy performance trends in MPT’s post‑acute portfolio commentary. (2025 Q4 earnings call).
HM Hospitales, eMDs, Median (duplicates noted)
HM Hospitales and eMDs were cited among international operators showing steady performance; Median appears repeatedly as a high‑performing rehab operator in Europe. (2026 earnings/news excerpts).
Quorum, Yale (YTFD), and other buyers
Quorum, Yale (YTFD) and other purchasers appear in transactional disclosures where MPT sold or arranged sales of specific facilities (e.g., Yale for Prospect facilities, Quorum rent stabilization updates). (FY2024 10‑K; 2022–2024 transaction notices).
Investment implications and risk checklist
- Concentration risk is real: a handful of large tenants (HSA, Circle, Priory, LifePoint, Swiss Medical) account for material revenue — tenant credit deterioration drives impairments and covenant events (company FY2024 commentary).
- Leases are long but re‑tenanting is active: long contractual terms underpin valuation, but MPT’s near‑term cash generation depends on re‑tenanting and staged rent ramps that management laid out through 2025 and into 2026 (earnings commentary).
- Global exposure increases complexity: tax, legal and operational differences across jurisdictions are company‑level constraints to execution (FY2024 10‑K).
- Operational playbook validated and tested: MPT has demonstrated the ability to sell assets, negotiate new master leases and secure refinancing for joint ventures — those are positive execution signals in the public record (FY2024 filings; 2025–2026 press).
Final read
MPT is a high‑leverage infrastructure REIT whose near‑term value depends on successful re‑tenanting and the credit quality of a concentrated set of healthcare operators. Monitor tenant‑specific legal notices, rent‑ramp schedules and realized gains/losses on sales to assess trajectory. For ongoing signal tracking and curated primary‑source summaries on MPT’s tenants, see Null Exposure: https://nullexposure.com/